Alto Neuroscience Inc (ANRO)
NYSE
News
Market Data
Register for real-time alerts, custom portfolio, and market movers
| Quarter End | Dec 2023 | Mar 2024 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -11.77M | -14.39M |
| Pre Tax Income | -11.22M | -13.42M |
| Net Income | -11.22M | -13.42M |
| Preferred Dividends | 0 | 0 |
| Basic Earnings Per Share (EPS) | 0 | 0 |
| EBIT | -11.77M | -14.39M |
| EBITDA | -11.67M | -14.29M |
| Year End December 30 2023 | 2022 | 2023 |
|---|---|---|
| USD ($) | USD ($) | |
| Total Revenue | 0 | 0 |
| Operating Income | -29.19M | -37.81M |
| Pre Tax Income | -27.71M | -36.31M |
| Net Income | -27.71M | -36.31M |
| Preferred Dividends | 0 | 0 |
| Basic Earnings Per Share (EPS) | -3.31 | -4.298 |
| EBIT | -27.46M | -37.81M |
| EBITDA | -28.85M | -37.44M |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
